Market Insights: Exploring Consumer Staples

Over the past year, the S&P 500 has climbed 20%, while the Nasdaq has surged even further, up 31%. This rapid growth is causing some investors to question whether the market may be getting a bit ahead of itself. Recent fluctuations suggest that a market pullback could be coming, though timing such corrections is tricky. Instead of trying to play catch-up, looking for value in sectors that have lagged could be a more prudent strategy.

ETF AI Analysts

One such sector to consider is consumer staples. The Consumer Staples Select Sector SPDR Fund (XLP) has seen about a 5% decline over the past year, in contrast to the overall market rally. Companies in this sector offer stability, acting as a defensive buffer in many portfolios and boasting steady, albeit modest, growth along with consistent demand.

Moreover, many of these companies have reasonable valuations and reliable dividend payouts. Let’s delve into three leading firms in this category: Church & Dwight (CHD), Procter & Gamble (PG), and Kimberly-Clark (KMB), to assess where the best current opportunities lie.

Church & Dwight (NYSE:CHD)

Church & Dwight, known for its Arm & Hammer Baking Soda, offers a variety of products like OxiClean and Spinbrush. Established in 1847 and headquartered in New Jersey, it exemplifies the consistency associated with consumer staples.

However, CHD has faced a decline of about 16.5% over the past year, although it’s still trading at around 25 times expected earnings for 2025, which is slightly above the S&P 500’s 23 times. Not the best deal, considering it’s a defensive stock with low growth.

The company has a commendable record of increasing dividends for 20 years, yet its current yield of 1.4% is just above the average of 1.1% for the S&P 500. While Church & Dwight is a trustworthy company, its valuation and yield might limit its upside compared to other contenders.

Is CHD a buy, hold, or sell?

The general sentiment on Wall Street appears as a medium buy; recent ratings indicate 7 buys, 5 holds, and 3 sells. The average price target of $98.86 suggests a potential upside of about 14% from where it’s currently priced.

Procter & Gamble (NYSE:PG)

Next up is Procter & Gamble, a significant player in consumer staples with a strong market value of $343 billion. Founded in 1837 in Cincinnati, it operates across multiple divisions with popular brands like Tide, Crest, and Pampers.

Even with a 9.3% drop in its stock over the last year, PG trades at a reasonable 21 times forward earnings for June 2026, making it cheaper than both the S&P 500 and Church & Dwight—though it doesn’t scream “bargain.”

What stands out is P&G’s dividend, offering a yield of 2.9%, which is notably higher than the market average. The company has successfully paid and increased dividends for an impressive 69 years, making it a favorite among income investors.

With strong finances and a robust portfolio, Procter & Gamble remains a sound long-term investment. Yet, those seeking more growth might find better options in the sector.

Is PG worth buying?

According to recent evaluations, PG is rated a medium buy; analyses show 11 buys, 7 holds, and no sells. The average price target of $169.44 points to a potential upside of around 16% in the next year.

Kimberly-Clark (NASDAQ:KMB)

Lastly, there’s Kimberly-Clark, another significant player in consumer staples with over 150 years behind it.

KMB stock has dropped 23.5% in the last year, a steeper decline than its rivals, largely due to news of its acquisition of KenVue, known for brands like Tylenol and Band-Aid, for approximately $48.7 billion. The market response has been cautious, reflecting concerns about short-term drops following major acquisitions.

However, the long-term prospects look intriguing. Merging Kimberly-Clark’s strong brands with KenVue’s health and personal care lineup could create a more diversified market leader.

From a valuation perspective, KMB stands out with its stock trading at just 13.5 times estimated earnings for 2025—a significant discount compared to its peers. Additionally, its dividend yield is appealing at 5%, with 52 consecutive years of increases, establishing it as a Dividend King.

Considering its low valuation, high yield, and the potential benefits from the KenVue acquisition, Kimberly-Clark might represent a compelling opportunity in an otherwise expensive market.

Is KMB a buy?

KMB holds a consensus rating suggesting it’s a good option, with 3 buys, 10 holds, and 1 sell in the last three months. The average price target of $120.15 implies upside potential of 15% from current levels.

Identifying the Best Choice

All three companies offer the hallmarks expected in consumer staples: stability, robust dividends, and resilience through different market conditions. Yet Kimberly-Clark seems to shine in terms of opportunity.

Church & Dwight has solid products but comes at a high price, and Procter & Gamble is a dependable choice, though priced close to fair. In contrast, Kimberly-Clark presents a blend of low valuation, attractive yield, and growth potential through its acquisition strategy.

While P&G stands as a pillar of dividend reliability, Kimberly-Clark might just deliver that sought-after mix of value, income, and upside in today’s consumer staples landscape.